Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

FDA recently announced these approvals: • Schwartz Bioscience's Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of early Parkinson's disease.

New FDA Approvals